株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

マイクロフルイディクスの世界市場:材料・コンポーネント (マイクロフルイディクスチップ/ポンプ/ニードル)・用途別の予測

Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022

発行 RNCOS E-Services Pvt. Ltd. 商品コード 486151
出版日 ページ情報 英文 90 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.17円で換算しております。
Back to Top
マイクロフルイディクスの世界市場:材料・コンポーネント (マイクロフルイディクスチップ/ポンプ/ニードル)・用途別の予測 Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022
出版日: 2018年09月14日 ページ情報: 英文 90 Pages
概要

当レポートでは、世界のマイクロフルイディクス (マイクロ流体) 市場について分析し、技術・製品の概要や、市場の基本構造・最新情勢、主な市場促進・抑制要因、市場規模の動向見通し (通算6年間分)、材料別・コンポーネント別・用途別・地域別の詳細動向、今後の資本取引・市場成長機会、主要企業のプロファイルなどを調査しております。

第1章 アナリストの見解

第2章 分析手法

第3章 マイクロフルイディクス (微小流体技術):概要

第4章 マイクロフルイディクス市場の概要

  • マイクロフルイディクス市場
  • 医療用マイクロフルイディクス市場

第5章 市場の促進要因と課題

  • 市場促進要因
  • 課題

第6章 市場区分

  • 材料別
    • セラミック製
    • ポリマー製
    • その他
  • コンポーネント別
    • マイクロフルイディクス用チップ市場
    • マイクロフルイディクス用ポンプ市場
    • マイクロフルイディクス用ニードル市場
    • その他
  • 用途別
    • 体外 (IV) 診断
    • 薬剤/ライフサイエンス研究
    • ドラッグデリバリ (薬剤送達)
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 他の国々 (RoW)

第7章 規制シナリオ

  • 北米 (米国など)
  • 欧州
  • アジア太平洋地域 (インド、中国)

第8章 市場の傾向と動静

  • マイクロフルイディクス研究に対する助成金交付の発表
  • 企業合併・買収 (M&A)

第9章 企業の評価

目次

Microfluidics is the science and technology discipline of controlling fluids, usually in the range of microliters to picolitres, in networks of channels with lowest dimensions. The report "Microfluidics Market - By Material (Ceramics, Polymers), By Components (Microfluidic Chips, Pumps, Needles), By Application (In-Vitro Diagnostics, Pharmaceutical Research, Drug Delivery) - World Forecasts to 2022" studies the market for the application of microfluidics in pharmaceutical, in-vitro diagnostics, and drug delivery devices. The market is anticipated to grow at a robust CAGR during the forecasted period, i.e. 2017-2022. This growth is likely to be driven by the rising demand for point-of-care devices, quick return on investments provided by microfluidics devices resulting in cost reductions, and miniaturization of microfluidic chips.

On the contrary, manufacturing difficulties and high capital investment for lab-on-chip devices are two of the major challenges faced by this sector. Other major factors such as tough incorporation of emerging microfluidic technologies into existing workflows, and complex and time consuming regulatory standards are hampering the growth of microfluidics market.

According to analysis, the market for microfluidic devices all over the world was worth US$ 3.6 Billion in 2017, and is poised for a double digit growth during the forecasted period (2017-2022). The new report also focuses on microfluidics market by material, such as ceramics, polymers, glass, and silicon; by components, such as microfluidic chips, pumps, and needles; by application, and territory. The In-Vitro diagnostics segment commands the largest share of the global microfluidics applications market. The large share of this segment is attributed to the increasing adoption of microfluidics for Point-of-Care & Clinical and Veterinary diagnostics application by major diagnostic companies, such as Roche, Becton Dickinson and Company, Abbott, and Cepheid amongst others. Similarly, in microfluidics by components segment, microfluidic chips accounted for the largest share. This large share is attributed to increasing usage of these chips in IVD application.

Based on material, in 2017, ceramics contributed the major share in microfluidics market. This high share is attributed to high chemical resistivity, versatility, and strength offered by ceramics in manufacturing of microfluidics devices.

Asia Pacific is poised to witness a lucrative growth in the coming years. This is attributed to the increasing mergers and acquisitions, and technological advancements in emerging countries. However, North America accounted for the largest share in 2017. The increasing adoption of microfluidics technology and the incessant launches of new products in the North American region are driving the market growth.

In addition, this study also covers latest trends and developments capturing the market since last few years. The report also includes the regulatory scenario in various countries across the globe.

The key vendors dominating the market space are Fluidigm Corp., Roche, Agilent Technologies Inc., Illumina, Inc., Shimadzu, Abbott, etc. Finally, the report covers strengths and weaknesses, and recent developments on the competitive front. Thus, it provides a comprehensive analysis of the microfluidics technology, which will enable investors and debut makers to design relevant business strategies to target the billion dollar market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Microfluidics - An Introduction

4. Microfluidics Market Overview

  • 4.1 Microfluidics Market
  • 4.2 Healthcare Microfluidics Market

5. Drivers & Challenges

  • 5.1 Drivers
    • 5.1.1 Rising Incidence of Chronic Diseases
    • 5.1.2 Increasing Demand of Point of Care Diagnostics
    • 5.1.3 Rising Application in Life Sciences Research
    • 5.1.4 Benefits of Miniaturization of Chip
  • 5.2 Challenges
    • 5.2.1 Manufacturing Difficulties & High Cost of Lab-on Chips Instruments
    • 5.2.2 Ambiguous Regulatory Framework
    • 5.2.3 Lack of Awareness in Emerging Markets

6. Market Segmentation

  • 6.1 By Material
    • 6.1.1 Ceramics
    • 6.1.2 Polymers
    • 6.1.3 Others
  • 6.2 By Components
    • 6.2.1 Microfluidics Chips Based Microfluidic Devices
    • 6.2.2 Microfluidics Pumps Based Microfluidic Devices
    • 6.2.3 Microfluidics Needles Based Microfluidic Devices
    • 6.2.4 Others
  • 6.3 By Applications
    • 6.3.1 In-Vitro Diagnostics
    • 6.3.2 Pharmaceutical & Life Sciences Research
    • 6.3.3 Drug Delivery
    • 6.3.4 Others
  • 6.4 By Geography
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Rest of World

7. Regulatory Scenario

  • 7.1 US
  • 7.2 Europe
  • 7.3 Asia-Pacific
    • 7.3.1 India
    • 7.3.2 China

8. Trends & Developments

  • 8.1 Grants Announced for Microfluidics Research
  • 8.2 Mergers & Acquisitions

9. Competitive Assessment

  • 9.1 Fluidigm Corporation
  • 9.2 F. Hoffmann-La Roche Ltd.
  • 9.3 Bio-Rad Laboratories, Inc.
  • 9.4 Thermo Fisher Scientific, Inc.
  • 9.5 Agilent Technologies, Inc.
  • 9.6 Perkin Elmer, Inc.
  • 9.7 Illumina, Inc.
  • 9.8 Shimadzu Corporation
  • 9.9 Danaher Corporation
  • 9.10 Abbott

List of Figures

  • Figure 4-1: Global - Microfluidics Market (Billion US$), 2017-2022
  • Figure 4-2: Share of Healthcare in Global Microfluidics Market (%), 2017 & 2022
  • Figure 4-3: Global - Healthcare Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-1: Global - Microfluidics Market by Material (%), 2017
  • Figure 6-2: Global - Microfluidics Market for Ceramics (Billion US$), 2017-2022
  • Figure 6-3: Global - Microfluidics Market for Polymers (Billion US$), 2017-2022
  • Figure 6-4: Global - Microfluidics Market for Others (Billion US$), 2017-2022
  • Figure 6-5: Global- Microfluidics Market by Components (%), 2017
  • Figure 6-6: Global - Microfluidics Chip Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-7: Global - Microfluidics Pumps Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-8: Global - Microfluidics Needles Based Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-9: Global - Other Microfluidic Components Market (Billion US$), 2017-2022
  • Figure 6-10: Global- Microfluidics Market by Applications (%), 2017
  • Figure 6-11: Global - Microfluidics Market for In-Vitro Diagnostics (Billion US$), 2017-2022
  • Figure 6-12: Global - Microfluidics Market for Pharmaceutical & Life Sciences Research (Billion US$), 2017-2022
  • Figure 6-13: Global - Microfluidics Market for Drug Delivery (Billion US$), 2017-2022
  • Figure 6-14: Global - Microfluidics Market for Other Applications (Billion US$), 2017-2022
  • Figure 6-15: Global - Microfluidics Market by Geography (%), 2017
  • Figure 6-16: North America - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-17: Europe - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-18: Asia Pacific - Microfluidics Market (Billion US$), 2017-2022
  • Figure 6-19: RoW - Microfluidics Market (Billion US$), 2017-2022
  • Figure 9-1: Fluidigm Corporation - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-2: Fluidigm Corporation - Revenue Breakup by Geography (%), 2017
  • Figure 9-3: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-4: F. Hoffmann-La Roche Ltd. - Revenue Breakup by Geography (%), 2017
  • Figure 9-5: Bio-Rad Laboratories, Inc. - Revenue Breakup by Business Segment (%), 2017
  • Figure 9-6: Bio-Rad Laboratories, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-7: Thermo Fisher Scientific Inc. - Revenue Breakup by Segments (%), 2017
  • Figure 9-8: Thermo Fisher Scientific Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-9: Agilent Technologies, Inc. - Revenue Breakup by Segments (%), 2017
  • Figure 9-10: Agilent Technologies, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-11: Perkin Elmer, Inc. - Revenue Breakup by Business Segments (%), 2017
  • Figure 9-12: Perkin Elmer, Inc. - Revenue Breakup by Geography (%), 2017
  • Figure 9-13: Illumina, Inc. - Net Sales Break up by Business Segments (%), 2017
  • Figure 9-14: Illumina, Inc. - Net Sales Break up by Geography (%), 2017
  • Figure 9-15: Shimadzu Corporation - Net Sales Break up by Business Segments (%), 2017
  • Figure 9-16: Shimadzu Corporation - Net Sales Break up by Geography (%), 2017
  • Figure 9-17: Danaher Corporation - Revenue by Segment (%), 2017
  • Figure 9-18: Danaher Corporation - Revenue by Geography (%), 2017
  • Figure 9-19: Abbott - Revenue by Segment (%), 2017
  • Figure 9-20: Abbott - Revenue by Geography (%), 2017

List of Tables

  • Table 5-1: Cost Involved in Microfluidics Chips
  • Table 6-1: Global - Cancer Incidences (Million), 2015 & 2025
  • Table 6-2: North America - Cancer Incidences (Million), 2015 & 2025
  • Table 6-3: Europe - Cancer Incidences (Million), 2015 & 2025
  • Table 6-4: Asia Pacific - Cancer Incidences (Million), 2015 & 2025
  • Table 6-5: Rest of the World - Cancer Incidences (Million), 2015 & 2025
  • Table 8-1: List of Grants Announced for Microfluidics Research (2014-2016)
  • Table 9-1: Fluidigm Corporation - Company Financials (Billion US$), 2015-2017
  • Table 9-2: F. Hoffmann-La Roche Ltd. - Company Financials (Billion US$), 2015-2017
  • Table 9-3: Bio-Rad Laboratories, Inc. - Company Financials (Billion US$), 2015-2017
  • Table 9-4: Thermo Fisher Scientific, Inc. - Key Financials (Million US$), 2015-2017
  • Table 9-5: Agilent Technologies, Inc. - Key Financials (Million US$), 2015-2017
  • Table 9-6: Perkin Elmer, Inc. - Company Financials (Million US$), 2015-2017
  • Table 9-7: Illumina, Inc. - Net Sales (Million US$), 2015-2017
  • Table 9-8: Shimadzu Corporation - Net Sales (Million US$), 2015-2017
  • Table 9-9: Danaher Corporation - Net Sales (Million US$), 2015-2017
  • Table 9-10: Abbott - Net Sales (Million US$), 2015-2017
Back to Top